{"id":"https://openalex.org/W2800566358","doi":"https://doi.org/10.1089/cap.2017.0155","title":"Antipsychotics in Dutch Youth: Prevalence, Dosages, and Duration of Use from 2005 to 2015","display_name":"Antipsychotics in Dutch Youth: Prevalence, Dosages, and Duration of Use from 2005 to 2015","publication_year":2018,"publication_date":"2018-03-29","ids":{"openalex":"https://openalex.org/W2800566358","doi":"https://doi.org/10.1089/cap.2017.0155","mag":"2800566358","pmid":"https://pubmed.ncbi.nlm.nih.gov/29641239"},"language":"en","primary_location":{"id":"doi:10.1089/cap.2017.0155","doi":"https://doi.org/10.1089/cap.2017.0155","is_oa":false,"landing_page_url":"https://doi.org/10.1089/cap.2017.0155","pdf_url":null,"source":{"id":"https://openalex.org/S198272637","display_name":"Journal of Child and Adolescent Psychopharmacology","issn_l":"1044-5463","issn":["1044-5463","1557-8992"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Child and Adolescent Psychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pure.eur.nl/en/publications/e29bb295-2bf5-409d-9da0-6241a0c62c47","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091407612","display_name":"Sanne Maartje Kloosterboer","orcid":"https://orcid.org/0000-0003-2573-4636","observed_orcids":["https://orcid.org/0000-0003-2573-4636"]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Sanne M. Kloosterboer","raw_affiliation_strings":["Department of Hospital Pharmacy, Erasmus Medical Centre, Rotterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hospital Pharmacy, Erasmus Medical Centre, Rotterdam, The Netherlands","institution_ids":["https://openalex.org/I2801952686"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026716064","display_name":"Catharina C. M. Schuiling\u2010Veninga","orcid":"https://orcid.org/0000-0002-8527-2608","observed_orcids":["https://orcid.org/0000-0002-8527-2608"]},"institutions":[{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Catharina C.M. Schuiling-Veninga","raw_affiliation_strings":["Department of Pharmacotherapy, -Epidemiology and -Economics, University of Groningen, Groningen, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacotherapy, -Epidemiology and -Economics, University of Groningen, Groningen, The Netherlands","institution_ids":["https://openalex.org/I169381384"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075477479","display_name":"Jens Bos","orcid":"https://orcid.org/0000-0001-9209-7564","observed_orcids":["https://orcid.org/0000-0001-9209-7564"]},"institutions":[{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Jens H.J. Bos","raw_affiliation_strings":["Department of Pharmacotherapy, -Epidemiology and -Economics, University of Groningen, Groningen, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacotherapy, -Epidemiology and -Economics, University of Groningen, Groningen, The Netherlands","institution_ids":["https://openalex.org/I169381384"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042903151","display_name":"Luuk J. Kalverdijk","orcid":"https://orcid.org/0000-0002-7908-1282","observed_orcids":["https://orcid.org/0000-0002-7908-1282"]},"institutions":[{"id":"https://openalex.org/I1334415907","display_name":"University Medical Center Groningen","ror":"https://ror.org/03cv38k47","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I1334415907"]},{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Luuk J. Kalverdijk","raw_affiliation_strings":["Department of Psychiatry, University of Groningen, University Medical Centre Groningen, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, University of Groningen, University Medical Centre Groningen, The Netherlands","institution_ids":["https://openalex.org/I1334415907","https://openalex.org/I169381384"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002674457","display_name":"Birgit C. P. Koch","orcid":"https://orcid.org/0000-0002-1202-3643","observed_orcids":["https://orcid.org/0000-0002-1202-3643"]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Birgit C.P. Koch","raw_affiliation_strings":["Department of Hospital Pharmacy, Erasmus Medical Centre, Rotterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hospital Pharmacy, Erasmus Medical Centre, Rotterdam, The Netherlands","institution_ids":["https://openalex.org/I2801952686"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112298127","display_name":"Gwen C. Dieleman","orcid":"https://orcid.org/0000-0001-9700-5606","observed_orcids":["https://orcid.org/0000-0001-9700-5606"]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Gwen C. Dieleman","raw_affiliation_strings":["Department of Child and Adolescent Psychiatry/Psychology, Erasmus Medical Centre, Rotterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Child and Adolescent Psychiatry/Psychology, Erasmus Medical Centre, Rotterdam, The Netherlands","institution_ids":["https://openalex.org/I2801952686"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027432288","display_name":"Manon H. J. Hillegers","orcid":"https://orcid.org/0000-0003-4877-282X","observed_orcids":["https://orcid.org/0000-0003-4877-282X"]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Manon H.J. Hillegers","raw_affiliation_strings":["Department of Child and Adolescent Psychiatry/Psychology, Erasmus Medical Centre, Rotterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Child and Adolescent Psychiatry/Psychology, Erasmus Medical Centre, Rotterdam, The Netherlands","institution_ids":["https://openalex.org/I2801952686"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5049406080","display_name":"Bram Dierckx","orcid":"https://orcid.org/0000-0002-5045-9894","observed_orcids":["https://orcid.org/0000-0002-5045-9894"]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"Bram Dierckx","raw_affiliation_strings":["Department of Child and Adolescent Psychiatry/Psychology, Erasmus Medical Centre, Rotterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Child and Adolescent Psychiatry/Psychology, Erasmus Medical Centre, Rotterdam, The Netherlands","institution_ids":["https://openalex.org/I2801952686"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5049406080"],"corresponding_institution_ids":["https://openalex.org/I2801952686"],"apc_list":null,"apc_paid":null,"fwci":1.9764,"has_fulltext":true,"cited_by_count":24,"citation_normalized_percentile":{"value":0.85012453,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"28","issue":"3","first_page":"173","last_page":"179"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9369999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9369999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.0340999998152256,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10272","display_name":"Mental Health Treatment and Access","score":0.00570000009611249,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.8930000066757202},{"id":"https://openalex.org/keywords/youth","display_name":"youth","score":0.6690000295639038},{"id":"https://openalex.org/keywords/children-and-adolescents","display_name":"children and adolescents","score":0.9610000252723694},{"id":"https://openalex.org/keywords/prevalence","display_name":"prevalence","score":0.40799999237060547},{"id":"https://openalex.org/keywords/dosage","display_name":"dosage","score":0.6790000200271606},{"id":"https://openalex.org/keywords/duration-of-use","display_name":"duration of use","score":0.949999988079071},{"id":"https://openalex.org/keywords/psychotropic-drugs","display_name":"psychotropic drugs","score":0.8799999952316284},{"id":"https://openalex.org/keywords/prescribing-trends","display_name":"prescribing trends","score":0.5450000166893005},{"id":"https://openalex.org/keywords/sex-differences","display_name":"sex differences","score":0.6000000238418579},{"id":"https://openalex.org/keywords/long-term-antipsychotic-use","display_name":"long-term antipsychotic use","score":0.7839999794960022},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.6480000019073486},{"id":"https://openalex.org/keywords/dutch-youth","display_name":"Dutch youth","score":0.5860000252723694}],"concepts":[{"id":"https://openalex.org/C162156334","wikidata":"https://www.wikidata.org/wiki/Q473420","display_name":"Dose","level":2,"score":0.9172127842903137},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.7877516746520996},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.76058429479599},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.7442564964294434},{"id":"https://openalex.org/C23276603","wikidata":"https://www.wikidata.org/wiki/Q158230","display_name":"Pharmacoepidemiology","level":3,"score":0.5672212839126587},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.46401724219322205},{"id":"https://openalex.org/C104863432","wikidata":"https://www.wikidata.org/wiki/Q614304","display_name":"Pharmacy","level":2,"score":0.451107382774353},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.42130976915359497},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.38779130578041077},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2655661702156067},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.20823362469673157},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.1648562252521515},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.11310872435569763},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[],"locations_count":6,"locations":[{"id":"doi:10.1089/cap.2017.0155","doi":"https://doi.org/10.1089/cap.2017.0155","is_oa":false,"landing_page_url":"https://doi.org/10.1089/cap.2017.0155","pdf_url":null,"source":{"id":"https://openalex.org/S198272637","display_name":"Journal of Child and Adolescent Psychopharmacology","issn_l":"1044-5463","issn":["1044-5463","1557-8992"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Child and Adolescent Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:29641239","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29641239","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of child and adolescent psychopharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:pure.eur.nl:openaire/e29bb295-2bf5-409d-9da0-6241a0c62c47","doi":null,"is_oa":true,"landing_page_url":"https://pure.eur.nl/en/publications/e29bb295-2bf5-409d-9da0-6241a0c62c47","pdf_url":null,"source":{"id":"https://openalex.org/S4306401266","display_name":"EUR Research Repository (Erasmus University Rotterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I913958620","host_organization_name":"Erasmus University Rotterdam","host_organization_lineage":["https://openalex.org/I913958620"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Kloosterboer, S, Schuiling-Veninga, CCM, Bos, JHJ, Kalverdijk, LJ, Koch, B, Dieleman, G, Hillegers, M & Dierckx, B 2018, 'Antipsychotics in Dutch Youth: Prevalence, Dosages, and Duration of Use from 2005 to 2015', Journal of Child and Adolescent Psychopharmacology, vol. 28, no. 3, pp. 173-179. https://doi.org/10.1089/cap.2017.0155","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:eur:oai:pure.eur.nl:publications/e29bb295-2bf5-409d-9da0-6241a0c62c47","doi":null,"is_oa":false,"landing_page_url":"https://pure.eur.nl/en/publications/e29bb295-2bf5-409d-9da0-6241a0c62c47","pdf_url":null,"source":{"id":"https://openalex.org/S4306401266","display_name":"EUR Research Repository (Erasmus University Rotterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I913958620","host_organization_name":"Erasmus University Rotterdam","host_organization_lineage":["https://openalex.org/I913958620"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Child and Adolescent Psychopharmacology, 28(3), 173 - 179. Mary Ann Liebert Inc.","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.rug.nl:openaire/ded9ef19-b023-4fd1-a189-0fb105a9dc1a","doi":null,"is_oa":true,"landing_page_url":"https://research.rug.nl/files/57157933/cap.2017.0155.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Kloosterboer, S M, Schuiling-Veninga, C C M, Bos, J H J, Kalverdijk, L J, Koch, B C P, Dieleman, G C, Hillegers, M H J & Dierckx, B 2018, 'Antipsychotics in Dutch Youth : Prevalence, Dosages, and Duration of Use from 2005 to 2015', Journal of Child and Adolescent Psychopharmacology, vol. 28, no. 3, pp. 173-179. https://doi.org/10.1089/cap.2017.0155","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:rug:oai:pure.rug.nl:publications/ded9ef19-b023-4fd1-a189-0fb105a9dc1a","doi":null,"is_oa":true,"landing_page_url":"https://research.rug.nl/en/publications/ded9ef19-b023-4fd1-a189-0fb105a9dc1a","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Child and Adolescent Psychopharmacology, 28(3), 173 - 179. MARY ANN LIEBERT, INC","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"pmh:oai:pure.eur.nl:openaire/e29bb295-2bf5-409d-9da0-6241a0c62c47","doi":null,"is_oa":true,"landing_page_url":"https://pure.eur.nl/en/publications/e29bb295-2bf5-409d-9da0-6241a0c62c47","pdf_url":null,"source":{"id":"https://openalex.org/S4306401266","display_name":"EUR Research Repository (Erasmus University Rotterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I913958620","host_organization_name":"Erasmus University Rotterdam","host_organization_lineage":["https://openalex.org/I913958620"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Kloosterboer, S, Schuiling-Veninga, CCM, Bos, JHJ, Kalverdijk, LJ, Koch, B, Dieleman, G, Hillegers, M & Dierckx, B 2018, 'Antipsychotics in Dutch Youth: Prevalence, Dosages, and Duration of Use from 2005 to 2015', Journal of Child and Adolescent Psychopharmacology, vol. 28, no. 3, pp. 173-179. https://doi.org/10.1089/cap.2017.0155","raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[{"id":"https://openalex.org/G3316608192","display_name":null,"funder_award_id":"836041011","funder_id":"https://openalex.org/F4320321007","funder_display_name":"ZonMw"}],"funders":[{"id":"https://openalex.org/F4320321007","display_name":"ZonMw","ror":"https://ror.org/01yaj9a77"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W257917513","https://openalex.org/W1507718585","https://openalex.org/W1867974463","https://openalex.org/W1984246160","https://openalex.org/W1995419446","https://openalex.org/W2014154872","https://openalex.org/W2028478180","https://openalex.org/W2035748256","https://openalex.org/W2038823933","https://openalex.org/W2058265391","https://openalex.org/W2079261236","https://openalex.org/W2081048798","https://openalex.org/W2083035693","https://openalex.org/W2087618621","https://openalex.org/W2098251401","https://openalex.org/W2102955710","https://openalex.org/W2105874672","https://openalex.org/W2113878979","https://openalex.org/W2130417382","https://openalex.org/W2148288398","https://openalex.org/W2254405940","https://openalex.org/W2367077642","https://openalex.org/W2465103360","https://openalex.org/W2466519839","https://openalex.org/W2519037422","https://openalex.org/W2532663360","https://openalex.org/W2577857898","https://openalex.org/W2739697668","https://openalex.org/W2762520970"],"related_works":["https://openalex.org/W2102955710","https://openalex.org/W4210893994","https://openalex.org/W2006319883","https://openalex.org/W2148288398","https://openalex.org/W7141141162","https://openalex.org/W2762520970","https://openalex.org/W2884248895","https://openalex.org/W2519037422","https://openalex.org/W2532663360","https://openalex.org/W3017260370"],"abstract_inverted_index":{"Objectives:":[0],"The":[1,47,137,186],"use":[2,39,141],"of":[3,38,40,49,61,86,109,140,159,188,201,216,225,243],"antipsychotic":[4,41,74,84,131,150,203,233],"drugs":[5,42,75,132,151,234],"by":[6],"youth":[7,69],"is":[8,28],"associated":[9],"with":[10,156],"serious":[11,252],"side":[12,253],"effects,":[13],"especially":[14],"when":[15],"prescribed":[16,73,130,176],"in":[17,33,43,56,67,115,121,195,206,210,221,228],"higher":[18],"dosages":[19,35,222],"and":[20,36,45,63,93,208,219,223],"for":[21,126,181,235,251],"a":[22,97,107,157,214],"longer":[23,153],"period.":[24,136],"Despite":[25,213],"this,":[26],"little":[27],"known":[29],"about":[30],"recent":[31],"trends":[32,55],"the":[34,127,134,174,196,199],"duration":[37,60,139,224],"children":[44],"adolescents.":[46],"aim":[48],"this":[50],"study":[51,135],"was":[52,142],"to":[53,78],"describe":[54],"prevalence,":[57],"incidence,":[58],"dosages,":[59],"use,":[62,226],"preceding":[64],"psychotropic":[65,193],"medication":[66],"Dutch":[68,99],"who":[70],"had":[71,190],"been":[72],"from":[76,96],"2005":[77,92,207],"2015.":[79],"Methods:":[80],"We":[81],"analyzed":[82],"84,828":[83],"prescriptions":[85],"youths":[87,114,175,189,230,244],"aged":[88],"0\u201319":[89],"years":[90,237],"between":[91],"2015,":[94],"derived":[95],"large":[98],"community":[100],"pharmacy-based":[101],"prescription":[102],"database":[103],"(IADB.nl).":[104],"Results:":[105],"Since":[106],"peak":[108],"9.8":[110],"users":[111],"per":[112,123],"1000":[113],"2009,":[116],"prevalence":[117],"rates":[118,218],"stabilized.":[119],"Dosages":[120],"milligram":[122],"kilogram":[124],"declined":[125],"most":[128],"frequently":[129],"during":[133],"median":[138,158],"6.0":[143],"(95%":[144,161,166],"CI":[145,162,167],"5.4\u20136.6)":[146],"months.":[147,185],"Boys":[148],"used":[149,179,191,232],"significantly":[152],"than":[154],"girls,":[155],"6.9":[160],"6.1\u20137.7)":[163],"versus":[164],"4.6":[165],"3.9\u20135.3)":[168],"months":[169],"(p":[170],"<":[171],"0.01).":[172],"Of":[173],"antipsychotics,":[177],"12.4%":[178],"them":[180],"at":[182,248],"least":[183],"48":[184],"majority":[187],"other":[192],"agents":[194],"year":[197],"before":[198],"start":[200],"an":[202],"drug":[204],"(62.4%":[205],"64.7%":[209],"2015).":[211],"Conclusions:":[212],"stabilization":[215],"usage":[217],"decline":[220],"one":[227],"eight":[229],"still":[231],"4":[236],"or":[238],"longer.":[239],"A":[240],"substantial":[241],"share":[242],"may,":[245],"therefore,":[246],"be":[247],"high":[249],"risk":[250],"effects.":[254]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":7},{"year":2018,"cited_by_count":2}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2018-05-17T00:00:00"}